Skip to content

Cervical pain block for pain management

To study and compare analgesic efficacy and safety of Ultrasound guided Transforaminal cervical nerve root block (CNRB) versus High Thoracic erector spinae plane block ( ESPB) in patients with lower cervical pain : A prospective randomized controlled study - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/06/088045
Enrollment
50
Registered
2025-06-02
Start date
Unknown
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: CERVICAL NERVE ROOT BLOCK AND ERECTOR SPINAE PLANE BLOCK: ULTRASOUND GUIDED CERVICAL NERVE ROOT BLOCK AND ERECTOR SPINAE PLANE BLOCK Intervention2: CERVICAL NERVE ROOT BLOCK AND ERECTOR

Sponsors

Palvi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Patients with upper extremity pain with or without neck pain. 2)Duration of pain more than 6 weeks not responding to conservative treatment(pharmacological) 3)Patient with cervical radicular pain from C5-T1 level pathology on MRI. 4)18-70 years of either gender 5)BMI between 18-35

Exclusion criteria

Exclusion criteria: 1) Patient refusal for consent. 2) Patients with bleeding disorders, deranged coagulation profile. 3) Wound or infection at the needle injection site for the block. 4) Hypersensitivity to any of the local anesthetics and study drugs. 5) Past history of cervical fractures or injury. 6) Patients with history of CVA with or without neurological deficit. 7) Patients with primary or metastatic malignancy. 8) Previous history of lower cervical spine surgery. 9) Congenital gross spinal deformity. 10) Pregnant females

Design outcomes

Primary

MeasureTime frame
To compare the analgesic efficacy and safety of cervical nerve root block (CNRB) vs High thoracic ESPB in patients with lower cervical painTimepoint: Intraprocedural assessment -At 0 minute, after 5 minutes of starting the procedure followed by 10 min assessment and then 30 min post procedure assessment for any drug related side effects or any procedural side effects also assessing for pain relief Post procedural Assessment via VAS and NDI score for pain relief at 1st week ,2nd week ,6th week, 8th week after the procedure by telephonically contacting the patients

Secondary

MeasureTime frame
1.To assess the decrease in pain by VAS & NDI before the procedure & after the procedure at 1-week, 2-week, 6-week, 8 weeks. 2. Any side effects during the procedure from the drugs used in the study. 3. Any intraprocedural complications (inadvertent intravascular, Intraneural, subarachnoid injection). 4. To access correlation between neck pain & screen time (time spent on computer, mobile phone). 5. To access improvement in daily work of the patient. Timepoint: Intraprocedural assesment -At 0 minute , after 5 minutes of starting the procedure followed by 10 min assessment & then 30 min post procedure assessment for any drug related side effects or any procedural side effects also assessing for pain relief. Post procedural - Assessment via VAS & NDI score for pain relief at 1st week ,2nd week ,6th week, 8th week after the procedure by telephonically contacting the patients.

Countries

India

Contacts

Public ContactPalvi

Dr Rajender Prasad government medical college Tanda Kangra Himachal Pradesh

drbharti203@gmail.com9418044928

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026